Gossamer Bio (GOSS) Net Equity Issued and Repurchased (2018 - 2026)
Gossamer Bio (GOSS) posted Net Equity Issued and Repurchased of $292,000 for Q1 2026, down 21.5% from $372,000 a year earlier and down 89.3% from the prior quarter.
Powered by 
Analysis
Gossamer Bio (GOSS) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
For FY2025, Gossamer Bio's Net Equity Issued and Repurchased came in at $3.66 million, up 481.1% from FY2024.
- Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -50.0% (FY2020 to FY2025).
- In prior years, Gossamer Bio's Net Equity Issued and Repurchased was $629,000 in FY2024 (-99.7%), $201.32 million in FY2023 (+67.8%), $119.95 million in FY2022 and $2.01 million in FY2021 (-98.3%).
- The Q1 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q3 2024.
- On a year-over-year basis, Net Equity Issued and Repurchased increased in two of the last four quarters, with an average decline of 3.3%.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q3 2025, with growth of 101.4%; the weakest was Q3 2024, with a decline of 99.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Gossamer Bio | 47.40 Mn | -425.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 292,000.00 |
| Dec 31, 2025 | 2.72 Mn |
| Sep 30, 2025 | 566,000.00 |
| Mar 31, 2025 | 372,000.00 |
| Sep 30, 2024 | 281,000.00 |
| Mar 31, 2024 | 348,000.00 |
| Sep 30, 2023 | 200.96 Mn |
| Mar 31, 2023 | 367,000.00 |
| Dec 31, 2022 | 18,000.00 |
| Sep 30, 2022 | 119.33 Mn |
| Mar 31, 2022 | 595,000.00 |
| Dec 31, 2021 | 371,000.00 |
| Sep 30, 2021 | 884,000.00 |
| Jun 30, 2021 | 744,000.00 |
| Mar 31, 2021 | 15,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Jun 30, 2020 | 117.08 Mn |
| Mar 31, 2020 | 15,000.00 |
| Jun 30, 2019 | 38,000.00 |
| Mar 31, 2019 | 291.27 Mn |
API Access
Gossamer Bio Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();